观察阿托伐他汀联合丹红注射液治疗椎基底动脉硬化致脑供血不足的临床疗效.doc

观察阿托伐他汀联合丹红注射液治疗椎基底动脉硬化致脑供血不足的临床疗效 目录 TOC \o 1-9 \h \z \u 目录 1 正文 1 文1：观察阿托伐他汀联合丹红注射液治疗椎基底动脉硬化致脑供血不足的临床疗效 1 1 资料与方法 3 2 结果 5 文2：阿托伐他汀联合丹红注射液治疗椎基底动脉硬化致脑供血不足的效 10 1资料与方法 10 参考文摘引言： 13 原创性声明（模板） 14 文章致谢（模板） 15 正文 观察阿托伐他汀联合丹红注射液治疗椎基底动脉硬化致脑供血不足的临床疗效 文1：观察阿托伐他汀联合丹红注射液治疗椎基底动脉硬化致脑供血不足的临床疗效 【Abstract】 Objective：To investigate the Atorvastatin joint Danhong Injection treatment of vertebral-basilar atherosclerosis induced clinical efficacy of cerebral ：From January 2014 to December 2014 in our hospital for treatment of vertebral-basal cerebral iufficiency caused by atherosclerosis in patients with 100 cases，the patients were randomly divided into two groups and the control group，50 cases in each implementation of the control group in which patients with conventional treatment，the observation group were to Atorvastatin and Danhong Injection on the basis of treatment，the treatment effect was observed and compared two groups of ：（1）The total efficiency of the treatment：patients in the observation group total effective rate of %， the treatment of patients in the control group， the total effective rate was %，the difference between groups was statistically significant （）.Conclusion：Atorvastatin joint Danhong Injection treatment of vertebral-basilar iufficiency of cerebral arteriosclerosis caused significant clinical effect，high security， can effectively improve symptoms， improve prognosis and to promote kind of combination therapy should be popularized in clinical practice，in order to help more patients benefit.　【Key words】 Atorvastatin； Danhong Injection； Vertebral-basilar arteriosclerosis； Cerebral iufficiency； Clinical efficacy Fit-author’s address：Zhumadian Central Hospital，Zhumadian 463000，China doi：/-.010 椎-基底动脉系统的生理功能为给脑干、小脑、丘脑、枕叶、颞叶底面等组织功血。当椎-基底动脉系统出现供血障碍时，可对上述供血部位造成不良影响，并可引发头痛、眩晕等临床症状[1]。引发椎-基底动脉系统障碍原因较多，除了年龄、遗传、家属史等不可调因素外，同时也包括高血压、高血脂、糖尿病等基础疾病等诱因[2]。近年来，我国椎-基底动脉系统疾病的发生率呈明显上升趋势，提示我国国民应注重自身的健康，对于出现眩晕等症状时应及时入院检查，以获得相应的诊断与治疗。椎-基底动脉硬化致脑供血不足具有较高的发病